NSAIDs double risk of bleeding in patients taking antithrombotics after myocardial infarction, study finds

Non-steroidal anti-inflammatory drugs (NSAIDs) more than double the risk of bleeding and also increase the risk of cardiovascular events among patients taking antithrombotic drugs after a myocardial infarction, even after short term treatment with NSAIDs, show results from a Danish study reported in JAMA.1

Guidelines recommend that dual antithrombotic therapy (aspirin and clopidogrel) should be prescribed to all patients who have a myocardial infarction for up to 12 months after the event, followed by …